Please login to the form below

infectious diseases

This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.

coli) infections in England. The report on antimicrobial resistance (AMR) has been published in The Lancet Infectious Diseases.

Sanofi to buy mRNA tech partner, Translate Bio, for $3.2bn

The relationship was expanded in 2020 to address current and future infectious diseases. ... Our goal is to unlock the potential of mRNA in other strategic areas such as immunology, oncology and rare diseases in addition to vaccines.”.
Sanofi raises profit forecast following positive Q2 results

The 400m annual investment will tackle key challenges, including thermostability and tolerability, that stand in the way of the technology becoming part of routine vaccination against a range of infectious diseases.
Infex Therapeutics partners with CRUK Newcastle for new early-stage COVID-19 drug

Peter Jackson (pictured above), executive director of Infex Therapeutics, said: “This is a key programme for us in terms of developing our pipeline of therapies to tackle infectious diseases and builds ... With the backing of the Hits-to-Leads
Sanofi to invest €400m annually in mRNA vaccines facility

However, key areas of innovation such as thermostability and tolerability improvements will be critical to unlock the applications of mRNA in routine vaccination against a broader set of infectious diseases and
GSK aims for £33bn in sales by 2031 as CEO Walmsley lays out ten-year strategy

That includes four core therapeutic areas – infectious diseases, HIV, oncology and immunology/respiratory.

More from news
Approximately 5 fully matching, plus 241 partially matching documents found.

A new era for UK-Japanese scientific research relations

In 1961, it established universal health insurance, it made huge advancements in the control and eradication of infectious diseases and, notably, it achieved the world’s highest life expectancy. ... Japan’s health system is seeing a corresponding
The pandemic preparedness paradox

There is no market for sporadic infectious diseases. Even the use of the word ‘market’ is incorrect. ... And we know how to translate academic inventions into medicines that can help patients, but today that’s not happening, because there is no
The search for effective drug treatments for COVID-19

medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious ... Diseases’ (NIAID) placebo-controlled phase
As COVID-19 takes over the world, biopharma fights back

I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID). ... IL-6 is a type of cytokine that plays an important role in immune response and is
We’ll need more than a spoonful of sugar to counter vaccine hesitancy

It is, therefore, critical that action is taken to stop the re-emergence of dangerous infectious diseases.

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Evoke KYNE promotes Dante DelVecchio to senior VP

In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
$New faces at HCA, P\S\L Group and Health Unlimited$ New faces at HCA, P\S\L Group and Health Unlimited

Over her 15-year career, Peck has worked across a range of healthcare communications areas, including oncology, dermatology, infectious diseases and more.
New hires at Bayer, Eisai and Accord Healthcare

Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

and infectious diseases.
Nabriva Therapeutics appoints chief medical officer

Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and

More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.

Wearable Technologies for Detecting Pre-Symptomatic Illness and Infections

Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. ... Among other things, she discusses
Understanding COVID-19 and varying responses across the globe

The Coalition for Epidemic Preparedness Innovation (CEPI), a global alliance financing and coordinating the development of vaccines against emerging infectious diseases, launched in 2017 and is needed now more than ever. ... These three factors all aid
Lucid Group adds more magic to the mix with four new hires

Betty has worked on a wide variety of medical education initiatives in various therapeutic areas including immuno-oncology, infectious diseases, transplantation and multiple sclerosis. ... Katherine has a background in oncology, neurology, metabolic
Antibiotic resistance: The silent pandemic

In a globalised world, infectious diseases can travel long distances in relatively short periods of time, making the problem of resistance one that is relevant to all seven billion of us
UK vs US: what makes a successful immunisation programme?

Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes ... We understand infectious diseases so well that we

More from PMHub
Approximately 2 fully matching, plus 11 partially matching documents found.

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Senior Medical Writer/ Copywriter, Flexible Location, Flexible D...: Salary TBC

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

No results were found

Add my company

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Ask the writers: Transitioning from academia to medical writing: Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset: By James Aird...
Guide: How to embrace behavioural science principles in healthcare MR...

Email:
Password: